41
TITLE: Platelet hyperactivation in maintained growth hormone-deficient childhood patients after therapy withdrawal as a putative earlier marker of increased cardiovascular risk
AUTHORS: Reis, F ; Campos, MV; Bastos, M; Almeida, L; Lourenco, M; Ferrer Antunes, CA; Palmeiro, A; Santos Dias, JD; Mesquita, JF; Carvalheiro, M; Teixeira, F ;
PUBLISHED: 2005, SOURCE: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, VOLUME: 90, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 3
42
TITLE: Lentiviral vectors for gene silencing in polyglutamine disorders: ataxin 3 gene silencing by lentiviral-mediated delivery of double-stranded RNAs  Full Text
AUTHORS: Alves, S; Deglon, N; de Almeida, LP;
PUBLISHED: 2004, SOURCE: 2nd European Conference and Practical Course on Towards Clinical Gene Therapy - Preclinical Gene Transfer Assessment in GENE THERAPY, VOLUME: 11
INDEXED IN: WOS
45
TITLE: Comparison of the changes in adenine nucleotides of rat liver mitochondria induced by tamoxifen and 4-hydroxytamoxifen  Full Text
AUTHORS: Cardoso, CMP; Moreno, AJM ; Almeida, LM; Custodio, JBA ;
PUBLISHED: 2003, SOURCE: 12th International Workshop on In Vitro Toxicology in TOXICOLOGY IN VITRO, VOLUME: 17, ISSUE: 5-6
INDEXED IN: Scopus WOS CrossRef: 21
46
TITLE: Dose-dependent neuroprotective effect of CNTF delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease
AUTHORS: Deglon, N; Regulier, E; de Almeida, LP; Sommer, B; Aebischer, P;
PUBLISHED: 2003, SOURCE: 13th Meeting of the Network of European CNS Transplantation and Restoration (NECTAR) in CELL TRANSPLANTATION, VOLUME: 12, ISSUE: 3
INDEXED IN: WOS
47
TITLE: Lentiviral vectors-mediated gene transfer as a new strategy to model Huntington's disease
AUTHORS: Deglon, N; de Almeida, LP; Palfi, S; Regulier, E; Bloch, J; Conde, F; Brouillet, E; Aebischer, P; Hantraye, P;
PUBLISHED: 2003, SOURCE: 13th Meeting of the Network of European CNS Transplantation and Restoration (NECTAR) in CELL TRANSPLANTATION, VOLUME: 12, ISSUE: 3
INDEXED IN: WOS
50
TITLE: 4-hydroxytamoxifen is a potent inhibitor of the mitochondrial permeability transition  Full Text
AUTHORS: Cardoso, CMP; Almeida, LM; Custodio, JBA ;
PUBLISHED: 2002, SOURCE: MITOCHONDRION, VOLUME: 1, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 13
Page 5 of 8. Total results: 80.